Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Eli Lilly describes BACE1 inhibitors

Oct. 4, 2016

Oncodesign discloses ALK-1 and/or ALK-2 inhibitors

Oct. 4, 2016

Bayer Pharma patents factor XIa inhibitors

Oct. 4, 2016

Genentech and Roche present JAK1 inhibitors

Oct. 3, 2016

Hetero Research Foundation develops antiviral agents

Oct. 3, 2016

Roche describes mGlu4 receptor positive allosteric modulators

Oct. 3, 2016

Bayer Pharma discloses coagulation factor XIa and kallikrein inhibitors

Oct. 3, 2016

Bayer Pharma patents prostanoid FP antagonists

Oct. 3, 2016

Washington University announces HGFA inhibitors

Sep. 30, 2016

Aurigene Discovery Technologies presents CDK inhibitors

Sep. 30, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...